Bristol-Myers Squibb

Bristol-Myers Squibb

Bristol-Myers SquibbBristol-Myers Squibb is a global biopharmaceutical company whose mission is to extend and enhance human life. For more information, visit www.bms.com.

Bristol-Myers Squibb RSS Channel

Filters
List of articles in category Bristol-Myers Squibb
Title Published Date
BioMotiv and Bristol-Myers Squibb announce the launch of Anteros Pharmaceuticals 05 February 2020
Bristol-Myers Squibb completes divestment of manufacturing facility in Anagni, Italy 07 January 2020
Bristol-Myers Squibb completes acquisition of Celgene, creating a leading biopharma company 25 November 2019
Bristol-Myers Squibb and Pfizer announce randomized, controlled trial to evaluate the effect of atrial fibrillation screening on health outcomes in older individuals 18 November 2019
Bayer, Bristol-Myers Squibb and Ono Pharmaceutical enter into a clinical collaboration agreement 22 July 2019
Bristol-Myers Squibb provides update on pending merger with Celgene 24 June 2019
Bristol-Myers Squibb announces post-closing leadership team 06 June 2019
Bristol-Myers Squibb reports first quarter financial results 25 April 2019
European Commission approves Opdivo (nivolumab) plus low-dose Yervoy (ipilimumab) for first-line treatment of patients with intermediate- and poor-risk advanced renal cell carcinoma 15 January 2019
Bristol-Myers Squibb to acquire Celgene to create a premier innovative biopharma company 03 January 2019
Bristol-Myers Squibb - Pfizer Alliance ACROPOLIS™ real-world data program grows to sample size of nearly one million lives worldwide 20 August 2018
Bristol-Myers Squibb and Nektar Therapeutics announce global development & commercialization collaboration for Nektar's CD122-biased agonist, NKTR-214 15 February 2018
Forxiga™ (dapagliflozin) now approved in European Union for treatment of type 2 diabetes 14 November 2012
Bristol-Myers Squibb Foundation Announces Six New Grants 14 October 2011
Bristol-Myers Squibb And Pfizer Announce Data Presentations For Apixaban 23 August 2011
Bristol-Myers Squibb and Roche Enter into a Clinical Collaboration Agreement 02 June 2011
APPRAISE-2 Study with Investigational Compound Apixaban Discontinued 21 November 2010
Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet Need in Patients with Atrial Fibrillation 26 August 2010
Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix® 16 September 2009
New Online Resource Launches For Patients With Chronic Myeloid Leukemia 09 July 2009
HPAPI (2)